Gene Therapies Targeting Mitochondrial Dysfunction in Parkinson's Disease Gene therapy entails the treatment of disease via delivery of a transgene that either replaces or corrects a defective gene or is generally supportive of cells in the disease environment (O'Connor and Boulis, 2015)
In addition, copper can affect mitogen-activated protein kinase kinase 1 (MEK1) and mitogen-activated protein kinase kinase 2 (MEK2) and enhance their phosphorylation of ERK1 and ERK2 in a dose-dependent manner, further promoting tumor cell proliferation (85)
Afterwards, the solution containing the refolded protein was purified via SEC in refolding buffer 2 on the kta Avant or Go system (Cytiva) with a Superdex 75 Increase 10/300 GL or HiLoad 16/600 Superdex 75 pg column (Cytiva) to check for and remove aggregates at a flow rate of 0.5 or 1 mL/min
Soymorphin-Soymorphin-5 (YPFVV), a -opioid agonist peptide derived from the soybean -glycin -subunit, inhibits hyperglycemia in KKAy mice without increasing plasma insulin levels while decreasing plasma and hepatic triglyceride (TG) levels and liver weight, and promotes plasma adiponectin concentration and adiponectin receptor subtype AdipoR2 mRNA expression in the liver, PPAR in the liver after oral administration of soymorphin-5 The mRNA expression of and its target genes was also increased, effectively improving glucose and lipid metabolism in KKAy mice, a type 2 diabetes model animal (75)
